Cargando…

Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization

The purpose of this study was to investigate the effect of diabetic retinopathy (DR) on longitudinal morphological changes in AMD-associated type 1 macular neovascularization using optical coherence tomography angiography (OCTA). We enrolled fifty treatment-naïve eyes with a diagnosis of exudative A...

Descripción completa

Detalles Bibliográficos
Autores principales: Viggiano, Pasquale, Landini, Luca, Grassi, Maria Oliva, Boscia, Giacomo, Borrelli, Enrico, Sborgia, Giancarlo, Alessio, Giovanni, Boscia, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539526/
https://www.ncbi.nlm.nih.gov/pubmed/37770616
http://dx.doi.org/10.1038/s41598-023-43635-4
_version_ 1785113518546092032
author Viggiano, Pasquale
Landini, Luca
Grassi, Maria Oliva
Boscia, Giacomo
Borrelli, Enrico
Sborgia, Giancarlo
Alessio, Giovanni
Boscia, Francesco
author_facet Viggiano, Pasquale
Landini, Luca
Grassi, Maria Oliva
Boscia, Giacomo
Borrelli, Enrico
Sborgia, Giancarlo
Alessio, Giovanni
Boscia, Francesco
author_sort Viggiano, Pasquale
collection PubMed
description The purpose of this study was to investigate the effect of diabetic retinopathy (DR) on longitudinal morphological changes in AMD-associated type 1 macular neovascularization using optical coherence tomography angiography (OCTA). We enrolled fifty treatment-naïve eyes with a diagnosis of exudative AMD and type 1 MNV. Twenty of 50 eyes were affected by mild DR. En face OCT angiography were examined for the MNV lesion area (mm(2)), the MNV flow area (mm(2)), the central macular thickness (CMT) and the BCVA. The OCTA acquisition was performed at the following visits: (i) before the loading phase (LP) of intravitreal injection of aflibercept (T1), and (ii) 1 month after the last intravitreal injection of loading phase comprising 3 monthly injections (T2). All morpho-functional parameters showed a significantly change at T2 compared to T1 values in both groups. Furthermore, we found a greater MNV area reduction after LP in eyes without DR (P = 0.023). With regard to the remaining parameters, no significant changes were found between two groups (P > 0.05). Our analysis revealed a less MNV area reduction after loading dose of anti-VEGF therapy in eyes affected by diabetic retinopathy.
format Online
Article
Text
id pubmed-10539526
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105395262023-09-30 Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization Viggiano, Pasquale Landini, Luca Grassi, Maria Oliva Boscia, Giacomo Borrelli, Enrico Sborgia, Giancarlo Alessio, Giovanni Boscia, Francesco Sci Rep Article The purpose of this study was to investigate the effect of diabetic retinopathy (DR) on longitudinal morphological changes in AMD-associated type 1 macular neovascularization using optical coherence tomography angiography (OCTA). We enrolled fifty treatment-naïve eyes with a diagnosis of exudative AMD and type 1 MNV. Twenty of 50 eyes were affected by mild DR. En face OCT angiography were examined for the MNV lesion area (mm(2)), the MNV flow area (mm(2)), the central macular thickness (CMT) and the BCVA. The OCTA acquisition was performed at the following visits: (i) before the loading phase (LP) of intravitreal injection of aflibercept (T1), and (ii) 1 month after the last intravitreal injection of loading phase comprising 3 monthly injections (T2). All morpho-functional parameters showed a significantly change at T2 compared to T1 values in both groups. Furthermore, we found a greater MNV area reduction after LP in eyes without DR (P = 0.023). With regard to the remaining parameters, no significant changes were found between two groups (P > 0.05). Our analysis revealed a less MNV area reduction after loading dose of anti-VEGF therapy in eyes affected by diabetic retinopathy. Nature Publishing Group UK 2023-09-28 /pmc/articles/PMC10539526/ /pubmed/37770616 http://dx.doi.org/10.1038/s41598-023-43635-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Viggiano, Pasquale
Landini, Luca
Grassi, Maria Oliva
Boscia, Giacomo
Borrelli, Enrico
Sborgia, Giancarlo
Alessio, Giovanni
Boscia, Francesco
Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization
title Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization
title_full Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization
title_fullStr Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization
title_full_unstemmed Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization
title_short Effects of diabetic retinopathy on longitudinal morphological changes in AMD-associated type 1 macular neovascularization
title_sort effects of diabetic retinopathy on longitudinal morphological changes in amd-associated type 1 macular neovascularization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539526/
https://www.ncbi.nlm.nih.gov/pubmed/37770616
http://dx.doi.org/10.1038/s41598-023-43635-4
work_keys_str_mv AT viggianopasquale effectsofdiabeticretinopathyonlongitudinalmorphologicalchangesinamdassociatedtype1macularneovascularization
AT landiniluca effectsofdiabeticretinopathyonlongitudinalmorphologicalchangesinamdassociatedtype1macularneovascularization
AT grassimariaoliva effectsofdiabeticretinopathyonlongitudinalmorphologicalchangesinamdassociatedtype1macularneovascularization
AT bosciagiacomo effectsofdiabeticretinopathyonlongitudinalmorphologicalchangesinamdassociatedtype1macularneovascularization
AT borrellienrico effectsofdiabeticretinopathyonlongitudinalmorphologicalchangesinamdassociatedtype1macularneovascularization
AT sborgiagiancarlo effectsofdiabeticretinopathyonlongitudinalmorphologicalchangesinamdassociatedtype1macularneovascularization
AT alessiogiovanni effectsofdiabeticretinopathyonlongitudinalmorphologicalchangesinamdassociatedtype1macularneovascularization
AT bosciafrancesco effectsofdiabeticretinopathyonlongitudinalmorphologicalchangesinamdassociatedtype1macularneovascularization